Strium will begin with synthetic US and Japanese stocks and commodities before expanding to real tokenized shares and asset-backed products with identity verificationStrium will begin with synthetic US and Japanese stocks and commodities before expanding to real tokenized shares and asset-backed products with identity verification

Startale, SBI launch blockchain for institutional FX, RWA trading

1 min read

Strium will begin with synthetic US and Japanese stocks and commodities before expanding to real tokenized shares and asset-backed products with identity verification.

Startale Group and Japan’s financial conglomerate SBI Holdings have launched Strium, a layer-1 blockchain designed to support exchange-layer and settlement infrastructure for institutional trading of foreign exchange, tokenized equities and real-world assets (RWAs).

Startale, SBI launch blockchain for institutional FX, RWA trading

The platform is designed as an exchange-layer network, according to an announcement shared with Cointelegraph.

“Tokenization is an inevitable trend, and equities tokenization is clearly the next big market,” said Sota Watanabe, CEO of Startale Group. He added that Strium aims to bridge the gap between traditional offchain finance and the onchain ecosystem by enabling compliant dividend and royalty payments.

Read more

Market Opportunity
Solayer Logo
Solayer Price(LAYER)
$0.09463
$0.09463$0.09463
-2.24%
USD
Solayer (LAYER) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.